Navigation Links
B. Braun and Amerinet Sign to Expand Infusion Therapy Offerings
Date:10/20/2009

BETHLEHEM, Pa., Oct. 20 /PRNewswire/ -- Furthering its commitment to provide patients with safe, efficient and environmentally responsible medication delivery, B. Braun Medical Inc. (B. Braun) today announced it has entered into a new, expanded agreement with Amerinet Inc., a leading national healthcare group purchasing organization.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO )

Effective November 1, the new five-year agreement will give Amerinet members access to a full line of B. Braun large and small-volume IV pumps, IV solutions, needle-free products, clinical nutrition, admixture and drug delivery services. A previous agreement gave Amerinet members access to other B. Braun products and services.

"This new contract builds on B. Braun's shared commitment to provide Amerinet members with an increased capability to deliver safe, efficient care to their patients," said Eric Steen, Senior Vice President and Chief Marketing Officer for B. Braun Medical Inc. "They will now have access to advanced technology and expertise to help them deliver quality healthcare."

Steen said this is the first time Amerinet members will have access to a full line of eco-friendly PVC-free and DEHP-free IV solutions.

One key product now available to Amerinet members is B. Braun's advanced SPACE Infusion System.

Designed with both adult and pediatric facilities in mind, the small, lightweight SPACE Infusion System allows for flexibility and easy transport within a number of care settings. At 9 inches by 6 inches and weighing only three pounds, the SPACE pumps can fit easily into a range of environments. The system, designed for higher acuity care facilities, offers a large drug library as well as the capability to build up to 24 pumps in a single bedside tower. Anesthesiologists also benefit from the compact size of the Perfusor® SPACE syringe pump in crowded operating room environments, where three pumps easily interlock on a pole clamp.

Amerinet members will also have access to B. Braun's Outlook® Safety Infusion System.

The easy-to-use Outlook® System with DoseGuard(TM) is designed to ensure the right patient is receiving the right drug and the right dose by an authorized clinician, and notifies clinicians if institution-defined dose limits are exceeded. Patient safety is further enhanced with DoseScan(TM) pump-based barcode technology with automated checks and balances that augment the manual procedures commonly in use. With these integrated technologies, the Outlook® Safety Infusion System helps reduce human error and enables hospitals to provide an unprecedented level of IV medication safety.

"We've had a long-standing relationship with B. Braun in a variety of product areas," said Gary Freeman, Vice President, Pharmacy for Amerinet. "This agreement gives our customers access to a more extensive group of B. Braun products."

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.

About Amerinet

As a leading national group purchasing organization, Amerinet strategically partners with healthcare providers to reduce costs and improve quality.

Through its Total Spend Management solutions and operational performance improvement programs, tools and services, Amerinet assists members in their efforts to reduce costs, improve efficiencies and create new revenue streams.

Supported by a team of clinical, data and supply chain experts, Amerinet offers a comprehensive portfolio of product and service contracts to address members' specific needs. Based in St. Louis, Amerinet serves acute and alternate care site healthcare providers nationwide. To learn more, visit www.amerinet-gpo.com.

SOURCE B. Braun Medical Inc.


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase
2. B. Braun Awarded Contract With HealthTrust Purchasing Group to Provide Pain Management Solutions
3. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
4. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
5. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
6. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
7. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
8. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
9. Cellectar Expands Clinical Management Team
10. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
11. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... ... On Tuesday, April 26, 2016 members of the HomeTown Health network, a ... Deal on SB 258, the “Rural Health Care Relief” Bill. , The bill, which ... to individuals and corporations which donate directly to a “rural hospital” in Georgia, and ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of skin ... blame for the majority of skin cancer deaths. More than 10,000 people are expected to ... at diagnosis is 62, it is the one of the most commonly diagnosed cancers in ...
Breaking Medicine News(10 mins):